| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin G | 66 | 2024 | 4540 | 6.210 |
Why?
|
| In Situ Hybridization | 18 | 2021 | 1900 | 4.800 |
Why?
|
| Autoimmune Diseases | 41 | 2023 | 2244 | 4.580 |
Why?
|
| Pancreatic Neoplasms | 80 | 2024 | 5349 | 4.340 |
Why?
|
| Bile Duct Neoplasms | 19 | 2022 | 602 | 3.630 |
Why?
|
| Carcinoma, Pancreatic Ductal | 39 | 2024 | 1724 | 3.610 |
Why?
|
| Cholangiocarcinoma | 19 | 2022 | 550 | 3.440 |
Why?
|
| Plasma Cells | 29 | 2021 | 591 | 3.210 |
Why?
|
| Pancreatitis | 17 | 2023 | 1098 | 2.460 |
Why?
|
| Cholangitis, Sclerosing | 7 | 2023 | 177 | 2.430 |
Why?
|
| Adenocarcinoma | 34 | 2024 | 6313 | 2.420 |
Why?
|
| Colonic Neoplasms | 15 | 2024 | 2523 | 2.330 |
Why?
|
| Pancreatitis, Chronic | 11 | 2019 | 281 | 2.260 |
Why?
|
| Barrett Esophagus | 8 | 2024 | 490 | 2.240 |
Why?
|
| Pancreas | 18 | 2021 | 1676 | 2.100 |
Why?
|
| Diagnosis, Differential | 65 | 2023 | 12951 | 2.050 |
Why?
|
| Esophageal Neoplasms | 13 | 2024 | 1648 | 2.020 |
Why?
|
| Bone Neoplasms | 16 | 2023 | 2531 | 1.970 |
Why?
|
| Immunohistochemistry | 53 | 2024 | 11070 | 1.880 |
Why?
|
| Colonic Polyps | 5 | 2023 | 551 | 1.700 |
Why?
|
| Liver Neoplasms | 18 | 2023 | 4313 | 1.500 |
Why?
|
| Carcinoma | 7 | 2023 | 2330 | 1.460 |
Why?
|
| Sialadenitis | 4 | 2012 | 45 | 1.440 |
Why?
|
| Granuloma, Plasma Cell | 3 | 2021 | 80 | 1.410 |
Why?
|
| Sarcoma | 10 | 2022 | 1785 | 1.400 |
Why?
|
| Albumins | 3 | 2019 | 575 | 1.380 |
Why?
|
| Biopsy | 32 | 2024 | 6768 | 1.350 |
Why?
|
| Soft Tissue Neoplasms | 9 | 2022 | 1152 | 1.280 |
Why?
|
| RANK Ligand | 2 | 2020 | 318 | 1.220 |
Why?
|
| Hashimoto Disease | 2 | 2024 | 105 | 1.200 |
Why?
|
| Colorectal Neoplasms | 16 | 2024 | 6852 | 1.190 |
Why?
|
| Neuroendocrine Tumors | 12 | 2022 | 650 | 1.170 |
Why?
|
| Giant Cell Tumor of Bone | 2 | 2019 | 117 | 1.090 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2021 | 2292 | 1.060 |
Why?
|
| Adenocarcinoma, Mucinous | 6 | 2022 | 517 | 1.050 |
Why?
|
| Tumor Microenvironment | 14 | 2024 | 3840 | 1.040 |
Why?
|
| Adenoma | 6 | 2024 | 2148 | 1.040 |
Why?
|
| Bile Ducts, Intrahepatic | 12 | 2022 | 296 | 1.010 |
Why?
|
| Middle Aged | 174 | 2024 | 219560 | 1.010 |
Why?
|
| Humans | 326 | 2024 | 758381 | 1.000 |
Why?
|
| Isocitrate Dehydrogenase | 8 | 2022 | 929 | 0.970 |
Why?
|
| Aged | 149 | 2024 | 168217 | 0.970 |
Why?
|
| Thyroiditis | 2 | 2024 | 86 | 0.970 |
Why?
|
| Pancreatic Cyst | 6 | 2012 | 367 | 0.940 |
Why?
|
| Gallbladder Neoplasms | 4 | 2015 | 190 | 0.920 |
Why?
|
| Male | 204 | 2024 | 358742 | 0.890 |
Why?
|
| Female | 207 | 2024 | 390316 | 0.890 |
Why?
|
| Stomach Neoplasms | 9 | 2024 | 1422 | 0.890 |
Why?
|
| Biopsy, Fine-Needle | 8 | 2015 | 1110 | 0.870 |
Why?
|
| Chordoma | 6 | 2021 | 346 | 0.850 |
Why?
|
| Adult | 133 | 2024 | 219916 | 0.840 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2022 | 951 | 0.840 |
Why?
|
| RNA-Binding Protein EWS | 3 | 2019 | 210 | 0.830 |
Why?
|
| Predictive Value of Tests | 30 | 2022 | 15225 | 0.830 |
Why?
|
| Colon | 6 | 2020 | 1788 | 0.820 |
Why?
|
| Liposarcoma | 3 | 2020 | 283 | 0.810 |
Why?
|
| Osteosarcoma | 7 | 2020 | 897 | 0.800 |
Why?
|
| Serum Albumin | 2 | 2015 | 673 | 0.790 |
Why?
|
| Mucins | 5 | 2022 | 568 | 0.780 |
Why?
|
| Immune System Diseases | 4 | 2017 | 258 | 0.780 |
Why?
|
| Hepatitis | 2 | 2020 | 229 | 0.770 |
Why?
|
| Neoplasm Invasiveness | 15 | 2022 | 3617 | 0.770 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2023 | 367 | 0.760 |
Why?
|
| Liver Abscess | 1 | 2021 | 81 | 0.760 |
Why?
|
| Aged, 80 and over | 73 | 2024 | 58681 | 0.760 |
Why?
|
| Retroperitoneal Space | 3 | 2019 | 171 | 0.750 |
Why?
|
| Neoadjuvant Therapy | 14 | 2022 | 2821 | 0.740 |
Why?
|
| Liver | 7 | 2021 | 7502 | 0.740 |
Why?
|
| Digestive System | 1 | 2022 | 244 | 0.740 |
Why?
|
| Tissue Array Analysis | 7 | 2024 | 551 | 0.730 |
Why?
|
| Chondroblastoma | 1 | 2020 | 48 | 0.730 |
Why?
|
| Orbital Pseudotumor | 4 | 2015 | 42 | 0.720 |
Why?
|
| Pathology, Clinical | 2 | 2022 | 375 | 0.710 |
Why?
|
| Prognosis | 52 | 2024 | 29558 | 0.710 |
Why?
|
| Carcinoma, Papillary | 3 | 2024 | 785 | 0.710 |
Why?
|
| Digestive System Diseases | 1 | 2022 | 151 | 0.700 |
Why?
|
| Pancreatectomy | 13 | 2021 | 810 | 0.680 |
Why?
|
| Dacryocystitis | 3 | 2018 | 68 | 0.670 |
Why?
|
| Paraproteinemias | 5 | 2013 | 246 | 0.660 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 102 | 0.650 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 1185 | 0.650 |
Why?
|
| Strongylida Infections | 1 | 2018 | 48 | 0.630 |
Why?
|
| Mastoiditis | 2 | 2016 | 37 | 0.630 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 7 | 2024 | 1086 | 0.620 |
Why?
|
| Skull Neoplasms | 1 | 2019 | 173 | 0.610 |
Why?
|
| Young Adult | 47 | 2021 | 58808 | 0.610 |
Why?
|
| RNA, Viral | 4 | 2021 | 2836 | 0.600 |
Why?
|
| Facial Bones | 1 | 2019 | 205 | 0.600 |
Why?
|
| Interferons | 2 | 2022 | 705 | 0.600 |
Why?
|
| Hypertension, Portal | 1 | 2020 | 226 | 0.590 |
Why?
|
| Lung | 5 | 2021 | 9985 | 0.590 |
Why?
|
| DNA Contamination | 1 | 2017 | 18 | 0.590 |
Why?
|
| Glycine | 1 | 2021 | 662 | 0.590 |
Why?
|
| Fibrosis | 14 | 2020 | 2038 | 0.580 |
Why?
|
| Salivary Glands | 1 | 2019 | 229 | 0.580 |
Why?
|
| Crohn Disease | 3 | 2022 | 2275 | 0.580 |
Why?
|
| Cysts | 3 | 2021 | 681 | 0.580 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.570 |
Why?
|
| Cell Differentiation | 14 | 2021 | 11471 | 0.550 |
Why?
|
| DNA Mismatch Repair | 4 | 2024 | 428 | 0.550 |
Why?
|
| Adenoma, Bile Duct | 1 | 2016 | 29 | 0.550 |
Why?
|
| Forkhead Transcription Factors | 6 | 2022 | 1611 | 0.550 |
Why?
|
| Embolism, Fat | 1 | 2016 | 46 | 0.540 |
Why?
|
| Fibroma | 1 | 2018 | 190 | 0.540 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2020 | 2420 | 0.540 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2022 | 730 | 0.540 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2018 | 192 | 0.540 |
Why?
|
| Phlebitis | 4 | 2024 | 35 | 0.530 |
Why?
|
| Gastrointestinal Tract | 4 | 2018 | 830 | 0.520 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 503 | 0.520 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 82 | 0.510 |
Why?
|
| Microsatellite Instability | 3 | 2020 | 715 | 0.510 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2016 | 120 | 0.510 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 3 | 2022 | 117 | 0.500 |
Why?
|
| Esophagitis, Peptic | 1 | 2016 | 76 | 0.500 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2015 | 169 | 0.500 |
Why?
|
| Hamartoma | 1 | 2017 | 235 | 0.500 |
Why?
|
| Pancreatic Diseases | 1 | 2017 | 343 | 0.490 |
Why?
|
| Insulinoma | 3 | 2012 | 121 | 0.490 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 7 | 2016 | 1725 | 0.490 |
Why?
|
| Checklist | 2 | 2020 | 827 | 0.490 |
Why?
|
| Liver Diseases | 3 | 2021 | 1296 | 0.480 |
Why?
|
| Pyrroles | 1 | 2021 | 1130 | 0.470 |
Why?
|
| Endosonography | 3 | 2009 | 607 | 0.470 |
Why?
|
| RNA, Messenger | 9 | 2022 | 12760 | 0.470 |
Why?
|
| Neck | 4 | 2015 | 731 | 0.470 |
Why?
|
| Immunosuppressive Agents | 5 | 2019 | 4158 | 0.460 |
Why?
|
| Colitis, Ulcerative | 3 | 2019 | 1919 | 0.460 |
Why?
|
| Tumor Suppressor Protein p53 | 11 | 2023 | 2912 | 0.460 |
Why?
|
| Fluorouracil | 9 | 2021 | 1631 | 0.460 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 9 | 2015 | 693 | 0.460 |
Why?
|
| Adenocarcinoma, Papillary | 2 | 2012 | 84 | 0.460 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2020 | 1245 | 0.450 |
Why?
|
| Antineoplastic Agents | 9 | 2021 | 13591 | 0.450 |
Why?
|
| Pituitary Gland | 1 | 2016 | 637 | 0.450 |
Why?
|
| Leucovorin | 7 | 2021 | 641 | 0.440 |
Why?
|
| Submandibular Gland | 3 | 2016 | 87 | 0.440 |
Why?
|
| Neoplasm Recurrence, Local | 17 | 2023 | 9273 | 0.430 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2013 | 59 | 0.430 |
Why?
|
| Cell Nucleus | 5 | 2016 | 2907 | 0.420 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2013 | 42 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3615 | 0.420 |
Why?
|
| Cystadenoma | 1 | 2012 | 79 | 0.420 |
Why?
|
| Pyrimidines | 4 | 2022 | 3006 | 0.410 |
Why?
|
| Colitis | 3 | 2024 | 1231 | 0.410 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 2012 | 56 | 0.400 |
Why?
|
| Tuberous Sclerosis | 2 | 2018 | 1030 | 0.400 |
Why?
|
| Glucocorticoids | 7 | 2020 | 2144 | 0.400 |
Why?
|
| Gene Rearrangement | 5 | 2021 | 1122 | 0.400 |
Why?
|
| Eosinophilia | 3 | 2018 | 559 | 0.400 |
Why?
|
| Abdominal Pain | 1 | 2018 | 1063 | 0.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2022 | 8506 | 0.400 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2009 | 110 | 0.390 |
Why?
|
| Retrospective Studies | 50 | 2022 | 80170 | 0.390 |
Why?
|
| Biopsy, Needle | 8 | 2019 | 1630 | 0.390 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2011 | 16 | 0.390 |
Why?
|
| Adolescent | 36 | 2021 | 87888 | 0.390 |
Why?
|
| Lymph Nodes | 10 | 2023 | 3485 | 0.390 |
Why?
|
| Keratins | 2 | 2021 | 497 | 0.390 |
Why?
|
| Mutation | 21 | 2024 | 29915 | 0.390 |
Why?
|
| Rectal Neoplasms | 3 | 2022 | 1152 | 0.380 |
Why?
|
| Gastric Mucosa | 5 | 2017 | 600 | 0.380 |
Why?
|
| Receptors, Notch | 3 | 2019 | 743 | 0.380 |
Why?
|
| Chondrosarcoma | 3 | 2023 | 296 | 0.380 |
Why?
|
| Abdomen | 1 | 2017 | 1129 | 0.380 |
Why?
|
| B-Lymphocytes | 5 | 2020 | 4738 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 2825 | 0.370 |
Why?
|
| Cystadenoma, Serous | 2 | 2009 | 100 | 0.370 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2022 | 2053 | 0.370 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 4 | 2022 | 211 | 0.370 |
Why?
|
| Orbital Diseases | 1 | 2012 | 178 | 0.360 |
Why?
|
| Pyrazoles | 1 | 2021 | 1990 | 0.360 |
Why?
|
| Submandibular Gland Diseases | 1 | 2010 | 22 | 0.350 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 3734 | 0.350 |
Why?
|
| Femur | 1 | 2016 | 1302 | 0.340 |
Why?
|
| Hyperplasia | 4 | 2023 | 1154 | 0.340 |
Why?
|
| Parotid Diseases | 1 | 2010 | 49 | 0.340 |
Why?
|
| Sjogren's Syndrome | 5 | 2012 | 235 | 0.340 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2022 | 153 | 0.340 |
Why?
|
| Puerperal Disorders | 1 | 2012 | 299 | 0.340 |
Why?
|
| Carcinoid Tumor | 1 | 2011 | 228 | 0.340 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1930 | 0.340 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 216 | 0.340 |
Why?
|
| Neurilemmoma | 1 | 2015 | 523 | 0.330 |
Why?
|
| Appendiceal Neoplasms | 1 | 2011 | 155 | 0.330 |
Why?
|
| DNA | 4 | 2022 | 7199 | 0.330 |
Why?
|
| Incidental Findings | 3 | 2013 | 694 | 0.330 |
Why?
|
| Immune Evasion | 2 | 2024 | 362 | 0.330 |
Why?
|
| Lung Diseases | 2 | 2018 | 1910 | 0.330 |
Why?
|
| Head | 1 | 2015 | 921 | 0.320 |
Why?
|
| Pyridines | 1 | 2021 | 2860 | 0.320 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 935 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 23 | 2021 | 20500 | 0.320 |
Why?
|
| Stem Cells | 6 | 2022 | 3521 | 0.320 |
Why?
|
| Osteitis Fibrosa Cystica | 1 | 2008 | 11 | 0.320 |
Why?
|
| Radiography | 9 | 2017 | 6955 | 0.310 |
Why?
|
| Cholestasis | 2 | 2022 | 377 | 0.310 |
Why?
|
| Paranasal Sinuses | 1 | 2011 | 265 | 0.310 |
Why?
|
| Cholecystitis | 1 | 2009 | 181 | 0.310 |
Why?
|
| Eosinophils | 4 | 2018 | 946 | 0.310 |
Why?
|
| Gastroesophageal Reflux | 1 | 2016 | 816 | 0.310 |
Why?
|
| Cholangitis | 1 | 2009 | 113 | 0.310 |
Why?
|
| Thyroid Gland | 2 | 2012 | 1168 | 0.310 |
Why?
|
| Goblet Cells | 1 | 2011 | 299 | 0.300 |
Why?
|
| Inflammation | 6 | 2022 | 10719 | 0.300 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2980 | 0.300 |
Why?
|
| Notochord | 1 | 2007 | 37 | 0.300 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 831 | 0.300 |
Why?
|
| Celiac Disease | 3 | 2022 | 822 | 0.300 |
Why?
|
| Treatment Outcome | 32 | 2024 | 64379 | 0.300 |
Why?
|
| Respiratory System | 1 | 2011 | 557 | 0.290 |
Why?
|
| Ilium | 1 | 2008 | 154 | 0.290 |
Why?
|
| Hepatectomy | 5 | 2021 | 559 | 0.290 |
Why?
|
| Liver Function Tests | 2 | 2020 | 523 | 0.290 |
Why?
|
| Fibrosarcoma | 2 | 2023 | 308 | 0.290 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2008 | 125 | 0.290 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2007 | 88 | 0.280 |
Why?
|
| Immune Complex Diseases | 1 | 2006 | 52 | 0.280 |
Why?
|
| Child | 27 | 2022 | 79813 | 0.280 |
Why?
|
| Recurrence | 10 | 2020 | 8426 | 0.280 |
Why?
|
| Pancreaticoduodenectomy | 6 | 2019 | 508 | 0.270 |
Why?
|
| Gastritis | 2 | 2019 | 199 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 10 | 2021 | 11709 | 0.260 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 2024 | 1355 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9160 | 0.260 |
Why?
|
| Colitis, Microscopic | 2 | 2019 | 72 | 0.260 |
Why?
|
| Sclerosis | 4 | 2015 | 210 | 0.260 |
Why?
|
| Follow-Up Studies | 20 | 2021 | 39060 | 0.260 |
Why?
|
| Leiomyoma | 3 | 2023 | 654 | 0.260 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 1406 | 0.260 |
Why?
|
| RNA | 6 | 2022 | 2716 | 0.250 |
Why?
|
| Disease-Free Survival | 13 | 2023 | 6821 | 0.250 |
Why?
|
| Intestines | 5 | 2022 | 1906 | 0.250 |
Why?
|
| Neoplasm Staging | 13 | 2023 | 11152 | 0.250 |
Why?
|
| Human papillomavirus 16 | 3 | 2016 | 266 | 0.250 |
Why?
|
| Hypoglycemia | 1 | 2012 | 881 | 0.250 |
Why?
|
| Ovarian Neoplasms | 4 | 2023 | 4876 | 0.250 |
Why?
|
| Esophagoscopy | 3 | 2020 | 390 | 0.240 |
Why?
|
| Esophagogastric Junction | 2 | 2024 | 341 | 0.240 |
Why?
|
| Intestinal Mucosa | 8 | 2022 | 3023 | 0.240 |
Why?
|
| SOXF Transcription Factors | 1 | 2024 | 31 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2024 | 6493 | 0.230 |
Why?
|
| Lymphoma | 3 | 2017 | 1896 | 0.230 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2021 | 611 | 0.230 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1345 | 0.230 |
Why?
|
| Sensitivity and Specificity | 14 | 2016 | 14641 | 0.230 |
Why?
|
| Epithelial Cells | 3 | 2020 | 3665 | 0.220 |
Why?
|
| Hypergammaglobulinemia | 3 | 2013 | 72 | 0.220 |
Why?
|
| beta 2-Microglobulin | 1 | 2024 | 328 | 0.220 |
Why?
|
| Gene Fusion | 3 | 2021 | 354 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7403 | 0.220 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2003 | 21 | 0.220 |
Why?
|
| Agrin | 2 | 2022 | 75 | 0.220 |
Why?
|
| Rheumatoid Nodule | 1 | 2003 | 15 | 0.220 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2023 | 330 | 0.220 |
Why?
|
| Pancreatic Ducts | 4 | 2021 | 329 | 0.220 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2019 | 546 | 0.220 |
Why?
|
| Papillomavirus Infections | 4 | 2022 | 1612 | 0.210 |
Why?
|
| Pericarditis, Constrictive | 1 | 2003 | 46 | 0.210 |
Why?
|
| Survival Rate | 13 | 2021 | 12721 | 0.210 |
Why?
|
| Prednisone | 5 | 2018 | 1565 | 0.210 |
Why?
|
| Immunologic Factors | 6 | 2016 | 1585 | 0.210 |
Why?
|
| RNA, Satellite | 1 | 2022 | 17 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2016 | 698 | 0.210 |
Why?
|
| Alkylating Agents | 1 | 2023 | 133 | 0.210 |
Why?
|
| Genes, Neoplasm | 2 | 2017 | 370 | 0.210 |
Why?
|
| Camptothecin | 2 | 2017 | 588 | 0.210 |
Why?
|
| Genes, ras | 4 | 2016 | 654 | 0.200 |
Why?
|
| Macrophages | 4 | 2020 | 5737 | 0.200 |
Why?
|
| Coloring Agents | 2 | 2023 | 560 | 0.200 |
Why?
|
| Disease Progression | 10 | 2024 | 13468 | 0.200 |
Why?
|
| Sarcoma, Synovial | 1 | 2023 | 151 | 0.200 |
Why?
|
| Head and Neck Neoplasms | 4 | 2021 | 2882 | 0.200 |
Why?
|
| Mikulicz' Disease | 2 | 2012 | 8 | 0.200 |
Why?
|
| Granuloma | 2 | 2022 | 327 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2011 | 2858 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2021 | 36285 | 0.200 |
Why?
|
| Urologic Neoplasms | 1 | 2005 | 320 | 0.190 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 195 | 0.190 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2022 | 224 | 0.190 |
Why?
|
| Intestinal Neoplasms | 3 | 2014 | 311 | 0.190 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2023 | 2504 | 0.190 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2021 | 3527 | 0.190 |
Why?
|
| Colitis, Ischemic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Carcinoma, Verrucous | 1 | 2021 | 27 | 0.190 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2021 | 67 | 0.190 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2016 | 633 | 0.190 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 98 | 0.190 |
Why?
|
| Necrosis | 2 | 2022 | 1604 | 0.180 |
Why?
|
| Cell Line, Tumor | 17 | 2022 | 16886 | 0.180 |
Why?
|
| Spinal Neoplasms | 1 | 2007 | 716 | 0.180 |
Why?
|
| Precancerous Conditions | 5 | 2017 | 977 | 0.180 |
Why?
|
| Desmin | 3 | 2020 | 99 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2015 | 4048 | 0.180 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2020 | 1110 | 0.180 |
Why?
|
| Signal Transduction | 9 | 2020 | 23341 | 0.180 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2021 | 136 | 0.180 |
Why?
|
| Enterocolitis | 1 | 2021 | 106 | 0.180 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 149 | 0.180 |
Why?
|
| Oncogene Fusion | 1 | 2020 | 81 | 0.170 |
Why?
|
| Phenotype | 8 | 2022 | 16534 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2001 | 1431 | 0.170 |
Why?
|
| Chronic Disease | 7 | 2019 | 9266 | 0.170 |
Why?
|
| Lymphocytosis | 2 | 2014 | 119 | 0.170 |
Why?
|
| Reproducibility of Results | 9 | 2021 | 20052 | 0.170 |
Why?
|
| Steroids | 2 | 2019 | 926 | 0.170 |
Why?
|
| Cell Dedifferentiation | 1 | 2020 | 122 | 0.170 |
Why?
|
| Child, Preschool | 13 | 2020 | 42058 | 0.170 |
Why?
|
| Dioxygenases | 1 | 2022 | 332 | 0.170 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2019 | 45 | 0.170 |
Why?
|
| Ketone Bodies | 1 | 2019 | 76 | 0.170 |
Why?
|
| Turkey | 1 | 2020 | 251 | 0.170 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2021 | 326 | 0.170 |
Why?
|
| Cadherins | 3 | 2016 | 898 | 0.160 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2009 | 100 | 0.160 |
Why?
|
| Epithelioid Cells | 2 | 2020 | 60 | 0.160 |
Why?
|
| Colonoscopy | 4 | 2020 | 1388 | 0.160 |
Why?
|
| Leprosy, Borderline | 1 | 1998 | 4 | 0.160 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.160 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2005 | 800 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 4 | 2020 | 2001 | 0.160 |
Why?
|
| Neuritis | 1 | 1998 | 36 | 0.160 |
Why?
|
| Hepatocytes | 2 | 2017 | 1230 | 0.160 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 9405 | 0.160 |
Why?
|
| Immunophenotyping | 3 | 2015 | 1871 | 0.160 |
Why?
|
| Budesonide | 1 | 2019 | 158 | 0.160 |
Why?
|
| Gastrectomy | 2 | 2021 | 670 | 0.160 |
Why?
|
| Histiocytes | 3 | 2009 | 98 | 0.160 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.160 |
Why?
|
| Histiocytosis, Sinus | 1 | 1998 | 46 | 0.160 |
Why?
|
| Image Enhancement | 4 | 2001 | 2880 | 0.150 |
Why?
|
| HLA Antigens | 2 | 2021 | 1368 | 0.150 |
Why?
|
| Cytodiagnosis | 2 | 2015 | 442 | 0.150 |
Why?
|
| Parasitic Diseases | 1 | 2018 | 76 | 0.150 |
Why?
|
| Neoplasms | 5 | 2023 | 22030 | 0.150 |
Why?
|
| Human papillomavirus 18 | 2 | 2016 | 125 | 0.150 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2019 | 473 | 0.150 |
Why?
|
| Pericardium | 1 | 2003 | 674 | 0.150 |
Why?
|
| Cyst Fluid | 2 | 2009 | 83 | 0.150 |
Why?
|
| Chi-Square Distribution | 4 | 2013 | 3425 | 0.150 |
Why?
|
| Treponema pallidum | 1 | 2018 | 47 | 0.150 |
Why?
|
| Cohort Studies | 12 | 2020 | 41252 | 0.150 |
Why?
|
| Synovial Cyst | 1 | 2018 | 35 | 0.150 |
Why?
|
| Endoscopy | 1 | 2008 | 1834 | 0.150 |
Why?
|
| Immunity | 2 | 2021 | 998 | 0.150 |
Why?
|
| Receptors, Virus | 1 | 2021 | 639 | 0.150 |
Why?
|
| Automation, Laboratory | 2 | 2015 | 103 | 0.150 |
Why?
|
| Esophagectomy | 1 | 2021 | 466 | 0.150 |
Why?
|
| Smad4 Protein | 1 | 2019 | 191 | 0.150 |
Why?
|
| Gastrinoma | 1 | 2017 | 20 | 0.150 |
Why?
|
| Echo-Planar Imaging | 2 | 2001 | 657 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2019 | 231 | 0.150 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2019 | 167 | 0.150 |
Why?
|
| Lymphadenitis | 1 | 1998 | 98 | 0.150 |
Why?
|
| Intestinal Diseases | 2 | 2016 | 505 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 300 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2022 | 5629 | 0.150 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 210 | 0.150 |
Why?
|
| Antibodies, Neoplasm | 1 | 2019 | 280 | 0.140 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2017 | 39 | 0.140 |
Why?
|
| Folate Receptor 1 | 1 | 2017 | 40 | 0.140 |
Why?
|
| DNA Mutational Analysis | 5 | 2020 | 4106 | 0.140 |
Why?
|
| Phenylurea Compounds | 2 | 2019 | 529 | 0.140 |
Why?
|
| Organoplatinum Compounds | 2 | 2017 | 405 | 0.140 |
Why?
|
| Autopsy | 1 | 2020 | 1003 | 0.140 |
Why?
|
| Spine | 2 | 2018 | 1111 | 0.140 |
Why?
|
| Polyuria | 1 | 2016 | 37 | 0.140 |
Why?
|
| Diarrhea | 2 | 2014 | 1317 | 0.140 |
Why?
|
| Angiotensins | 1 | 2017 | 143 | 0.140 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2014 | 346 | 0.140 |
Why?
|
| Postoperative Complications | 5 | 2016 | 15638 | 0.140 |
Why?
|
| DNA, Neoplasm | 3 | 2012 | 1745 | 0.140 |
Why?
|
| Survival Analysis | 6 | 2020 | 10112 | 0.140 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2016 | 21 | 0.140 |
Why?
|
| Antirheumatic Agents | 3 | 2015 | 1368 | 0.130 |
Why?
|
| Chromosome Aberrations | 3 | 2012 | 1764 | 0.130 |
Why?
|
| Mucous Membrane | 1 | 2019 | 656 | 0.130 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2016 | 40 | 0.130 |
Why?
|
| Deoxycytidine | 3 | 2019 | 870 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1829 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2020 | 5248 | 0.130 |
Why?
|
| Diabetes Insipidus | 1 | 2016 | 144 | 0.130 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2016 | 62 | 0.130 |
Why?
|
| Mitotic Index | 1 | 2016 | 161 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 677 | 0.130 |
Why?
|
| Terminology as Topic | 3 | 2012 | 1533 | 0.130 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2015 | 28 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2010 | 6347 | 0.130 |
Why?
|
| Stomach Diseases | 1 | 2017 | 133 | 0.130 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1723 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2019 | 696 | 0.130 |
Why?
|
| Mice | 25 | 2024 | 81107 | 0.130 |
Why?
|
| Rectum | 1 | 2020 | 895 | 0.130 |
Why?
|
| Coronary Vessels | 3 | 2001 | 3072 | 0.130 |
Why?
|
| Glutarates | 2 | 2014 | 244 | 0.130 |
Why?
|
| Orbital Myositis | 2 | 2013 | 25 | 0.130 |
Why?
|
| Mouth | 1 | 2018 | 380 | 0.130 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.120 |
Why?
|
| Syphilis | 1 | 2018 | 243 | 0.120 |
Why?
|
| Ligands | 1 | 2022 | 3258 | 0.120 |
Why?
|
| Stomach | 1 | 2019 | 694 | 0.120 |
Why?
|
| Radiography, Abdominal | 1 | 2018 | 532 | 0.120 |
Why?
|
| Azacitidine | 1 | 2017 | 334 | 0.120 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 226 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 869 | 0.120 |
Why?
|
| Diplopia | 1 | 2016 | 215 | 0.120 |
Why?
|
| Anus Neoplasms | 1 | 2019 | 329 | 0.120 |
Why?
|
| Foreign Bodies | 2 | 2014 | 397 | 0.120 |
Why?
|
| Mastocytosis, Systemic | 1 | 2016 | 102 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1356 | 0.120 |
Why?
|
| Carcinoma in Situ | 3 | 2012 | 796 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2017 | 783 | 0.120 |
Why?
|
| Arginase | 1 | 2015 | 80 | 0.120 |
Why?
|
| Cell Proliferation | 8 | 2020 | 10417 | 0.120 |
Why?
|
| Granuloma, Lethal Midline | 1 | 2014 | 4 | 0.120 |
Why?
|
| DNA Methylation | 4 | 2017 | 4373 | 0.120 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 2 | 2013 | 178 | 0.120 |
Why?
|
| Pain | 3 | 2016 | 5065 | 0.120 |
Why?
|
| Biliary Tract Diseases | 1 | 2015 | 157 | 0.120 |
Why?
|
| Infant | 6 | 2019 | 36054 | 0.120 |
Why?
|
| Lymph Node Excision | 2 | 2023 | 1303 | 0.120 |
Why?
|
| DNA, Viral | 3 | 2016 | 2194 | 0.120 |
Why?
|
| Lymphocytes | 4 | 2024 | 2610 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 104 | 0.120 |
Why?
|
| Antibody-Producing Cells | 1 | 2014 | 140 | 0.120 |
Why?
|
| Placenta | 2 | 2020 | 1702 | 0.120 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 98 | 0.110 |
Why?
|
| Spasm | 1 | 2014 | 130 | 0.110 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2014 | 23 | 0.110 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 560 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2019 | 1594 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2014 | 126 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2023 | 1439 | 0.110 |
Why?
|
| Intestine, Small | 2 | 2013 | 1207 | 0.110 |
Why?
|
| Lymphatic Metastasis | 5 | 2022 | 2943 | 0.110 |
Why?
|
| Burns, Chemical | 1 | 2014 | 122 | 0.110 |
Why?
|
| Ethmoid Sinusitis | 1 | 2013 | 25 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2001 | 1333 | 0.110 |
Why?
|
| Transcription Factors | 6 | 2019 | 12096 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2020 | 3783 | 0.110 |
Why?
|
| Muscle, Smooth | 2 | 2019 | 924 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 4023 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2019 | 1047 | 0.110 |
Why?
|
| England | 1 | 2015 | 524 | 0.110 |
Why?
|
| Gastroscopy | 2 | 2012 | 209 | 0.110 |
Why?
|
| Genotype | 4 | 2016 | 12945 | 0.110 |
Why?
|
| Animals | 31 | 2024 | 167777 | 0.110 |
Why?
|
| Sirtuins | 1 | 2016 | 320 | 0.110 |
Why?
|
| Homeostasis | 3 | 2022 | 3302 | 0.110 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2013 | 32 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2014 | 638 | 0.110 |
Why?
|
| Vasculitis | 1 | 2017 | 522 | 0.110 |
Why?
|
| Helicobacter pylori | 1 | 2016 | 376 | 0.110 |
Why?
|
| Helicobacter Infections | 1 | 2016 | 385 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2019 | 1112 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 4 | 2015 | 7377 | 0.110 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 345 | 0.110 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2015 | 649 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 1986 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2022 | 4087 | 0.100 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18125 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2014 | 207 | 0.100 |
Why?
|
| Germinal Center | 1 | 2015 | 378 | 0.100 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2016 | 277 | 0.100 |
Why?
|
| Stress Fibers | 1 | 2012 | 55 | 0.100 |
Why?
|
| Femoral Fractures | 1 | 2016 | 375 | 0.100 |
Why?
|
| United States | 8 | 2021 | 72140 | 0.100 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2013 | 110 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2014 | 491 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2021 | 23883 | 0.100 |
Why?
|
| Pleural Effusion | 1 | 2015 | 342 | 0.100 |
Why?
|
| Lacrimal Apparatus | 2 | 2011 | 223 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2443 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 2 | 2014 | 336 | 0.100 |
Why?
|
| Remission Induction | 4 | 2020 | 2388 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 98 | 0.100 |
Why?
|
| Osteoclasts | 1 | 2016 | 710 | 0.100 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 171 | 0.100 |
Why?
|
| Proton Pump Inhibitors | 2 | 2016 | 529 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2433 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5818 | 0.100 |
Why?
|
| Fasting | 1 | 2018 | 1599 | 0.100 |
Why?
|
| Anal Canal | 2 | 2019 | 372 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 1600 | 0.100 |
Why?
|
| Paresthesia | 1 | 2012 | 162 | 0.100 |
Why?
|
| Meningitis | 1 | 2013 | 218 | 0.100 |
Why?
|
| Drainage | 1 | 2017 | 1161 | 0.100 |
Why?
|
| Viral Load | 1 | 2020 | 3321 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2017 | 5952 | 0.100 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 3609 | 0.100 |
Why?
|
| Tracheal Stenosis | 1 | 2013 | 226 | 0.100 |
Why?
|
| Cell Count | 3 | 2016 | 1835 | 0.090 |
Why?
|
| Thyroid Function Tests | 1 | 2012 | 289 | 0.090 |
Why?
|
| Heterocyclic Compounds | 3 | 2020 | 246 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1740 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2013 | 202 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2018 | 4114 | 0.090 |
Why?
|
| Embolism, Cholesterol | 1 | 2010 | 32 | 0.090 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2011 | 49 | 0.090 |
Why?
|
| DNA, Satellite | 1 | 2011 | 67 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 291 | 0.090 |
Why?
|
| Maxillary Neoplasms | 1 | 2010 | 47 | 0.090 |
Why?
|
| RNA, Neoplasm | 2 | 2011 | 749 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 162 | 0.090 |
Why?
|
| Granulocytes | 1 | 2012 | 550 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2001 | 8946 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22031 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4567 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 1357 | 0.090 |
Why?
|
| Communication | 2 | 2023 | 3846 | 0.090 |
Why?
|
| Stromal Cells | 3 | 2021 | 1326 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1803 | 0.090 |
Why?
|
| DNA-Binding Proteins | 4 | 2022 | 9575 | 0.090 |
Why?
|
| Chromatin | 3 | 2024 | 2938 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 1078 | 0.090 |
Why?
|
| Sublingual Gland | 1 | 2009 | 11 | 0.090 |
Why?
|
| Lysosomes | 1 | 2015 | 919 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 3 | 2008 | 1705 | 0.090 |
Why?
|
| beta Catenin | 2 | 2016 | 1043 | 0.090 |
Why?
|
| Mandibular Neoplasms | 1 | 2010 | 130 | 0.080 |
Why?
|
| Carmine | 1 | 2009 | 4 | 0.080 |
Why?
|
| Genomics | 2 | 2017 | 5789 | 0.080 |
Why?
|
| Alcian Blue | 1 | 2009 | 13 | 0.080 |
Why?
|
| Cause of Death | 1 | 2020 | 3674 | 0.080 |
Why?
|
| Fever | 1 | 2017 | 1617 | 0.080 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2011 | 895 | 0.080 |
Why?
|
| Bronchoscopy | 1 | 2015 | 910 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 769 | 0.080 |
Why?
|
| Hyperinsulinism | 1 | 2012 | 400 | 0.080 |
Why?
|
| Mice, SCID | 4 | 2019 | 2626 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3533 | 0.080 |
Why?
|
| Reference Values | 5 | 2019 | 4919 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3774 | 0.080 |
Why?
|
| Polyps | 1 | 2011 | 197 | 0.080 |
Why?
|
| Cecum | 1 | 2010 | 233 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2015 | 1803 | 0.080 |
Why?
|
| Aortitis | 1 | 2010 | 74 | 0.080 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2012 | 225 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2796 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2009 | 60 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1460 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2001 | 2325 | 0.080 |
Why?
|
| Sacrum | 2 | 2008 | 277 | 0.080 |
Why?
|
| Nasal Cavity | 1 | 2011 | 304 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1765 | 0.080 |
Why?
|
| Histones | 2 | 2016 | 2577 | 0.080 |
Why?
|
| Organometallic Compounds | 3 | 2020 | 648 | 0.080 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13245 | 0.080 |
Why?
|
| Jaundice | 1 | 2009 | 97 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 186 | 0.080 |
Why?
|
| Epigenesis, Genetic | 4 | 2017 | 3754 | 0.080 |
Why?
|
| Esophagus | 1 | 2014 | 1023 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 1957 | 0.080 |
Why?
|
| Wound Healing | 1 | 2019 | 2783 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1557 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2010 | 184 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 2 | 2007 | 513 | 0.080 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2009 | 103 | 0.080 |
Why?
|
| Ampulla of Vater | 1 | 2008 | 149 | 0.080 |
Why?
|
| Eye Diseases | 1 | 2013 | 651 | 0.080 |
Why?
|
| Coccyx | 1 | 2007 | 13 | 0.080 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2011 | 533 | 0.070 |
Why?
|
| Metformin | 1 | 2015 | 907 | 0.070 |
Why?
|
| Appendectomy | 1 | 2011 | 431 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2014 | 615 | 0.070 |
Why?
|
| Eating | 1 | 2014 | 1536 | 0.070 |
Why?
|
| Integrins | 1 | 2012 | 836 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2021 | 4641 | 0.070 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 151 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 104 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 938 | 0.070 |
Why?
|
| Gallbladder | 1 | 2009 | 305 | 0.070 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2007 | 34 | 0.070 |
Why?
|
| Dihematoporphyrin Ether | 1 | 2007 | 33 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 3755 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1322 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2018 | 2083 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 459 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1895 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 273 | 0.070 |
Why?
|
| North America | 2 | 2014 | 1276 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2010 | 386 | 0.070 |
Why?
|
| Combined Modality Therapy | 5 | 2022 | 8530 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6068 | 0.070 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2011 | 304 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2017 | 1150 | 0.070 |
Why?
|
| Hypocalcemia | 1 | 2008 | 199 | 0.070 |
Why?
|
| Cell Nucleolus | 1 | 2007 | 156 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 1218 | 0.070 |
Why?
|
| Boston | 3 | 2020 | 9304 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 385 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1507 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 17768 | 0.070 |
Why?
|
| Delphi Technique | 1 | 2010 | 829 | 0.070 |
Why?
|
| Nephritis, Interstitial | 1 | 2007 | 154 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 344 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2007 | 361 | 0.070 |
Why?
|
| Risk Factors | 5 | 2024 | 73806 | 0.070 |
Why?
|
| Pelvic Bones | 1 | 2008 | 270 | 0.070 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4258 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 2413 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 2800 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2018 | 2001 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2013 | 2205 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2019 | 1339 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1113 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1084 | 0.060 |
Why?
|
| Databases, Bibliographic | 1 | 2005 | 130 | 0.060 |
Why?
|
| Collagen | 3 | 2020 | 2635 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3071 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1083 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2211 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 620 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2127 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2024 | 3156 | 0.060 |
Why?
|
| Organoids | 2 | 2024 | 729 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 409 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1997 | 0.060 |
Why?
|
| Mucin-1 | 1 | 2009 | 539 | 0.060 |
Why?
|
| Urine | 1 | 2005 | 363 | 0.060 |
Why?
|
| Photochemotherapy | 2 | 2009 | 819 | 0.060 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 9518 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 609 | 0.060 |
Why?
|
| Pneumonia | 1 | 2015 | 2129 | 0.060 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 12440 | 0.060 |
Why?
|
| Hemangioma | 1 | 2009 | 727 | 0.060 |
Why?
|
| Proteins | 2 | 2023 | 6026 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1094 | 0.060 |
Why?
|
| ras Proteins | 3 | 2014 | 1049 | 0.060 |
Why?
|
| Arylsulfotransferase | 1 | 2023 | 28 | 0.050 |
Why?
|
| Contrast Media | 6 | 2013 | 5298 | 0.050 |
Why?
|
| Melanoma | 1 | 2022 | 5691 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2007 | 1570 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2011 | 1373 | 0.050 |
Why?
|
| Endoderm | 1 | 2024 | 160 | 0.050 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2002 | 16 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2016 | 778 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 4549 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2009 | 807 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1825 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 618 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2020 | 54136 | 0.050 |
Why?
|
| Observer Variation | 3 | 2017 | 2600 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2019 | 4485 | 0.050 |
Why?
|
| Integrin alpha2 | 1 | 2022 | 39 | 0.050 |
Why?
|
| Sulfotransferases | 1 | 2023 | 149 | 0.050 |
Why?
|
| Gadolinium | 3 | 2002 | 959 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2003 | 204 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14354 | 0.050 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 15785 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 1888 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2016 | 1593 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4342 | 0.050 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2021 | 46 | 0.050 |
Why?
|
| Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
| Ischemia | 1 | 2010 | 1863 | 0.050 |
Why?
|
| Time Factors | 7 | 2021 | 39873 | 0.050 |
Why?
|
| Transfection | 2 | 2019 | 5779 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 2013 | 0.050 |
Why?
|
| Lamivudine | 1 | 2022 | 362 | 0.050 |
Why?
|
| Exons | 2 | 2019 | 2387 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 4901 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5098 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2019 | 8297 | 0.040 |
Why?
|
| Colon, Sigmoid | 1 | 2001 | 124 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 240 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 463 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2019 | 15 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3574 | 0.040 |
Why?
|
| Cell Movement | 3 | 2018 | 5201 | 0.040 |
Why?
|
| ROC Curve | 3 | 2016 | 3563 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2557 | 0.040 |
Why?
|
| Papillomaviridae | 2 | 2016 | 1121 | 0.040 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2019 | 74 | 0.040 |
Why?
|
| DNA Polymerase II | 1 | 2020 | 104 | 0.040 |
Why?
|
| Nomograms | 1 | 2021 | 237 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2019 | 194 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2020 | 194 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2022 | 865 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2019 | 109 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 431 | 0.040 |
Why?
|
| Massachusetts | 4 | 2019 | 8823 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8651 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 1793 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4902 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2001 | 249 | 0.040 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.040 |
Why?
|
| Mucin 5AC | 2 | 2009 | 97 | 0.040 |
Why?
|
| Carcinoma, Lobular | 1 | 2003 | 489 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2020 | 310 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.040 |
Why?
|
| Mycobacterium leprae | 1 | 1998 | 95 | 0.040 |
Why?
|
| Heart Failure | 1 | 2003 | 11594 | 0.040 |
Why?
|
| Incidence | 4 | 2019 | 21273 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 2019 | 320 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2008 | 1377 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2000 | 635 | 0.040 |
Why?
|
| Antigens, CD | 3 | 2014 | 3997 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2019 | 232 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 868 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2002 | 551 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2019 | 2533 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3433 | 0.040 |
Why?
|
| Uncertainty | 1 | 2022 | 751 | 0.040 |
Why?
|
| Ileum | 1 | 2020 | 555 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 785 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14481 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 1998 | 151 | 0.040 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2018 | 279 | 0.030 |
Why?
|
| Kidney | 2 | 2016 | 7016 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2015 | 5864 | 0.030 |
Why?
|
| RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 105 | 0.030 |
Why?
|
| Hematoxylin | 1 | 2016 | 60 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2016 | 69 | 0.030 |
Why?
|
| Neutrophils | 1 | 2009 | 3765 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3680 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 802 | 0.030 |
Why?
|
| PPAR delta | 1 | 2016 | 40 | 0.030 |
Why?
|
| Neprilysin | 2 | 2009 | 471 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2019 | 370 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2012 | 1791 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4415 | 0.030 |
Why?
|
| Cell Division | 2 | 2014 | 4459 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 6293 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2003 | 1096 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2012 | 1893 | 0.030 |
Why?
|
| Genes, APC | 1 | 2016 | 145 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5779 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 262 | 0.030 |
Why?
|
| Neoplasm, Residual | 2 | 2012 | 1007 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 1759 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2001 | 1561 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2016 | 763 | 0.030 |
Why?
|
| International Cooperation | 2 | 2012 | 1430 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 2017 | 406 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 1020 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 568 | 0.030 |
Why?
|
| Silver Compounds | 1 | 2014 | 23 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7590 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 798 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 1387 | 0.030 |
Why?
|
| Dyspnea | 1 | 2003 | 1344 | 0.030 |
Why?
|
| Nasal Septum | 1 | 2016 | 130 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2014 | 68 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1998 | 708 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 695 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.030 |
Why?
|
| Spiral Cone-Beam Computed Tomography | 1 | 2015 | 34 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1387 | 0.030 |
Why?
|
| Antibody Diversity | 1 | 2014 | 72 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2019 | 727 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 772 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 1245 | 0.030 |
Why?
|
| Algorithms | 2 | 2012 | 13959 | 0.030 |
Why?
|
| Receptors, CXCR | 1 | 2014 | 52 | 0.030 |
Why?
|
| CA-19-9 Antigen | 1 | 2014 | 106 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2014 | 142 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1090 | 0.030 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2014 | 101 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2014 | 405 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 435 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 631 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 745 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3096 | 0.030 |
Why?
|
| Maxillary Diseases | 1 | 2013 | 48 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3069 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2017 | 964 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12604 | 0.030 |
Why?
|
| Proton Pumps | 1 | 2013 | 29 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1060 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2020 | 815 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2015 | 259 | 0.030 |
Why?
|
| Autoantibodies | 2 | 2013 | 2118 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 256 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 428 | 0.030 |
Why?
|
| Telomere | 1 | 2019 | 931 | 0.030 |
Why?
|
| Consensus | 2 | 2014 | 3099 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2019 | 18942 | 0.030 |
Why?
|
| Gastric Fundus | 1 | 2012 | 37 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 316 | 0.030 |
Why?
|
| DNA Replication | 1 | 2020 | 1410 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cardia | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 16 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 267 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2850 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1907 | 0.030 |
Why?
|
| Actins | 1 | 2020 | 2049 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2022 | 1526 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6803 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2014 | 221 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7583 | 0.030 |
Why?
|
| Registries | 2 | 2019 | 8176 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 4809 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 622 | 0.020 |
Why?
|
| Prostate | 1 | 2020 | 1791 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 714 | 0.020 |
Why?
|
| Cytokines | 2 | 2018 | 7338 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2222 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.020 |
Why?
|
| Surface Properties | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1694 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2019 | 2666 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 913 | 0.020 |
Why?
|
| Prolapse | 1 | 2011 | 63 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 555 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2013 | 383 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 580 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4839 | 0.020 |
Why?
|
| Pressure | 1 | 2014 | 1155 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12096 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Workflow | 1 | 2015 | 850 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2014 | 564 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 276 | 0.020 |
Why?
|
| Exophthalmos | 1 | 2011 | 97 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 468 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1660 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1745 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 2012 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 1075 | 0.020 |
Why?
|
| Graft Survival | 1 | 2001 | 3794 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2012 | 243 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 726 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 996 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2012 | 296 | 0.020 |
Why?
|
| Autoantigens | 1 | 2014 | 877 | 0.020 |
Why?
|
| Oxygen | 1 | 2001 | 4192 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1484 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3056 | 0.020 |
Why?
|
| Coronary Disease | 2 | 2001 | 5917 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2019 | 2860 | 0.020 |
Why?
|
| Awareness | 1 | 2014 | 644 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2011 | 221 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2001 | 4451 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1444 | 0.020 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2010 | 168 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2010 | 163 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2014 | 855 | 0.020 |
Why?
|
| Cyclic S-Oxides | 1 | 2009 | 25 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2000 | 1627 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22006 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1713 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2008 | 51 | 0.020 |
Why?
|
| Calcinosis | 2 | 2013 | 1467 | 0.020 |
Why?
|
| Age Factors | 2 | 2016 | 18357 | 0.020 |
Why?
|
| Oral Surgical Procedures | 1 | 2010 | 166 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2010 | 384 | 0.020 |
Why?
|
| Thiadiazoles | 1 | 2009 | 64 | 0.020 |
Why?
|
| Mucin-6 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Glucagonoma | 1 | 2008 | 14 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 2008 | 106 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2385 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1634 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2016 | 1728 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2008 | 50 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2011 | 293 | 0.020 |
Why?
|
| Iopamidol | 1 | 2008 | 186 | 0.020 |
Why?
|
| Myocardium | 1 | 2001 | 4690 | 0.020 |
Why?
|
| Pregnancy | 2 | 2020 | 29742 | 0.020 |
Why?
|
| Quinazolines | 1 | 2014 | 1360 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 1955 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 3339 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5781 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2016 | 1956 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2551 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1664 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2010 | 427 | 0.020 |
Why?
|
| Metaplasia | 1 | 2008 | 321 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 2210 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6127 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2007 | 348 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1501 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3507 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2432 | 0.020 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2006 | 64 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2009 | 823 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 933 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1120 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2836 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2007 | 449 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1262 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2204 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3443 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 2896 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1533 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1632 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7980 | 0.020 |
Why?
|
| Longevity | 1 | 2012 | 1050 | 0.010 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1984 | 21 | 0.010 |
Why?
|
| Swine | 1 | 2014 | 5892 | 0.010 |
Why?
|
| Ectromelia | 1 | 1984 | 28 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2011 | 3602 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2868 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 6209 | 0.010 |
Why?
|
| Syndrome | 1 | 2010 | 3262 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 506 | 0.010 |
Why?
|
| Glutens | 1 | 2006 | 240 | 0.010 |
Why?
|
| Mitochondria | 1 | 2017 | 3584 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12436 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 1840 | 0.010 |
Why?
|
| Regeneration | 1 | 2012 | 1505 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5490 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2057 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 1477 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2283 | 0.010 |
Why?
|
| Hypertension | 1 | 2003 | 8503 | 0.010 |
Why?
|
| Hospitals, General | 1 | 2007 | 795 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9312 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5787 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2882 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2012 | 2606 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2003 | 573 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2723 | 0.010 |
Why?
|
| Models, Biological | 1 | 2018 | 9461 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8554 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 1489 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 4937 | 0.010 |
Why?
|
| Ultrasonography, Mammary | 1 | 2003 | 239 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1842 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2019 | 26182 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5031 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2000 | 270 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3867 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15773 | 0.010 |
Why?
|
| Epilepsy | 1 | 2015 | 3269 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3990 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2006 | 697 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3527 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10505 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 1486 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2002 | 875 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 1870 | 0.010 |
Why?
|
| Skin | 1 | 2011 | 4464 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6439 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1984 | 1414 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 3838 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10747 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 21017 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11894 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15594 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 12870 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2001 | 2509 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 2427 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2001 | 2560 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2001 | 6363 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 11336 | 0.000 |
Why?
|
| Genes, Recessive | 1 | 1984 | 626 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1984 | 499 | 0.000 |
Why?
|
| India | 1 | 1984 | 2329 | 0.000 |
Why?
|